Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Caitlin E. Cox

December 11, 2019

News Conference News AHA 2019

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Yael L. Maxwell

November 17, 2019

News Daily News

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

Todd Neale

November 07, 2019

News Daily News

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

L.A. McKeown

November 01, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

October 21, 2019

Presentation TCT Abstracts Posters 2019

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Presenter: Young-Hyo Lim

September 29, 2019

Presentation TCT 2019

Case Resolution: How Did I Treat and What Happened?

Presenter: Amit Vora

September 26, 2019

Presentation TCT 2019

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Presenter: Bernard Chevalier

September 26, 2019

Presentation TCT 2019

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

Presenter: Robert Welsh

September 26, 2019

Presentation TCT 2019

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

Presenter: Francesco Franchi

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Insights From SMART CHOICE

Presenter: Joo-Yong Hahn

September 26, 2019

Presentation TCT 2019

Insights From STOP DAPT-2

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

Insights From TWILIGHT

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

Insights From GLOBAL LEADERS and GLASSY

Presenter: Pascal Vranckx

September 26, 2019

Presentation TCT 2019

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

Presenter: Robert Byrne

September 26, 2019

Presentation TCT 2019

Case Introduction: DAPT Dilemma After a Complex PCI in a High Bleeding Risk Patient

Presenter: Amit Vora

September 26, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

News Conference News ESC 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Caitlin E. Cox

September 06, 2019

News Conference News ESC 2019

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Yael L. Maxwell

September 03, 2019

Advertisement

CV Risk Factors Largely Explain Sex Gap in NSTE ACS Outcomes: TIMI Trials

Aspirin Discontinuation Safe, Effective Strategy in ACS Subset: TWILIGHT

Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms

Morphine Not Linked to Increased Short-term Mortality in STEMI: Meta-analysis

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Comparison of Real-World Bleeding and Ischemic Event Rate in P2Y12 Inhibitors After Percutaneous Coronary Intervention: Analysis of Korean National Insurance Claims Data

Case Resolution: How Did I Treat and What Happened?

The Approach to the High Bleeding Risk Patient: The Dos and the Don’ts!

Long-Term Antithrombotic Therapy After PCI: How Do I Incorporate COMPASS Into My Practice?

De-Escalation: When and How? — The Role of Platelet Function and Genetic Testing

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Insights From SMART CHOICE

Insights From STOP DAPT-2

Insights From TWILIGHT

Insights From GLOBAL LEADERS and GLASSY

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

Case Introduction: DAPT Dilemma After a Complex PCI in a High Bleeding Risk Patient

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Young MI Patients’ Ischemic Risk Extends at Least Two Decades

Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content